FLGT
Fulgent Genetics, Inc.Company with tickers: FLGT
CIK
1674930
CUSIP
359664109
Shares Outstanding
28,400,623
13F Activity (30d)
144 filings
138 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $71,138,000 | USD | 2026-03-31 | 10-Q | 2026-05-01 |
| Cost of Revenue | $49,648,000 | USD | 2026-03-31 | 10-Q | 2026-05-01 |
| Gross Profit | $21,490,000 | USD | 2026-03-31 | 10-Q | 2026-05-01 |
| Operating Expenses | $56,112,000 | USD | 2026-03-31 | 10-Q | 2026-05-01 |
| Research & Development | $14,176,000 | USD | 2026-03-31 | 10-Q | 2026-05-01 |
| Operating Income | $-34,622,000 | USD | 2026-03-31 | 10-Q | 2026-05-01 |
| Net Income | $-24,826,000 | USD | 2026-03-31 | 10-Q | 2026-05-01 |
| EPS (Basic) | — | ||||
| EPS (Diluted) | — |